Alphabet Inc.
Mountain View, CA 4 processed 13Fs on this site, 2025 Q3 to 2026 Q2
- $99.1B
- 28 holdings
- 2026 Q2
- +2367.2% QoQ
- Top 5 98.5%
AUM over time
Book
| ASTS, Ast Spacemobile | Hold | 8,943,486 | $72.63 | $650M | — | — | |
| PL, Planet Labs PBC | Hold | 31,942,641 | $19.72 | $630M | — | — | |
| RVMD, Revolution Medicines | Reduce −19.1% | 3,345,102 | $79.65 | $266M | −788,175 | +$73M | |
| ARM, Arm Holdings | Hold | 1,960,784 | $109.31 | $214M | — | — | |
| Freshworks | Hold | 16,206,643 | $12.25 | $199M | — | — | |
| PATH, Uipath | Hold | 7,034,337 | $16.39 | $115M | — | — | |
| GTLB, Gitlab | Hold | 2,724,712 | $37.53 | $102M | — | — | |
| TEM, Tempus AI | Hold | 1,551,102 | $59.05 | $92M | — | — | |
| DXCM, DexCom | Hold | 1,036,937 | $66.37 | $69M | — | — | |
| MAZE, Maze Therapeutics | Reduce −42.4% | 1,388,583 | $41.43 | $58M | −1,023,888 | −$5M | |
| PRME, Prime Medicine | Hold | 16,562,498 | $3.47 | $57M | — | — | |
| BBOT | Hold | 2,823,126 | $12.52 | $35M | — | — | |
| Relay Therapeutics | Hold | 1,568,753 | $8.46 | $13M | — | — | |
| Vera Therapeutics | Hold | 241,264 | $50.64 | $12M | — | — | |
| GLUE, Monte Rosa Therapeutics | Reduce −49.1% | 744,948 | $15.68 | $12M | −719,067 | +$832K | |
| Sana Biotechnology | Hold | 2,812,500 | $4.07 | $11M | — | — | |
| LYEL, Lyell Immunopharma | Hold | 293,256 | $30.78 | $9M | — | — | |
| BEAM, Beam Therapeutics | Hold | 321,604 | $27.72 | $8.9M | — | — | |
| FIG, Figma | Hold | 215,582 | $37.37 | $8.1M | — | — | |
| OSCR, Oscar Health | Hold | 481,988 | $14.37 | $6.9M | — | — | |
| WGS, Genedx | Hold | 22,711 | $130.06 | $3M | — | — | |
| Exact Sciences | Hold | 23,205 | $101.56 | $2.4M | — | — | |
| Spero Therapeutics | Hold | 889,979 | $2.33 | $2.1M | — | — | |
| AUTL, Autolus Therapeutics | Hold | 698,262 | $1.99 | $1.4M | — | — | |
| Hyperfine | Hold | 898,720 | $0.9800 | $881K | — | — | |
| Tenaya Therapeutics | Hold | 915,705 | $0.7100 | $650K | — | — | |
| Quince Therapeutics | Hold | 189,122 | $3.35 | $634K | — | — | |
| FULC, Fulcrum Therapeutics | Hold | 14,262 | $11.31 | $161K | — | — | |
| RGEN, Repligen | Hold | 383 | $163.86 | $63K | — | — |
Exits / last held
Gone since 2025 Q3, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| Metsera | Exit | 0 | $52.33 | $198M | −3,783,528 | −$198M | |
| DNTH, Dianthus Therapeutics | Exit | 0 | $39.35 | $8.2M | −208,697 | −$8.2M | |
| FHTX, Foghorn Therapeutics | Exit | 0 | $4.89 | $2.4M | −500,901 | −$2.4M | |
| TSHA, Taysha Gene Therapies | Exit | 0 | $3.27 | $2.1M | −640,882 | −$2.1M | |
| Tscan Therapeutics | Exit | 0 | $1.82 | $2M | −1,077,080 | −$2M | |
| Holding | Exit | 0 | $1.25 | $1.9M | −1,513,644 | −$1.9M | |
| GUTS, Fractyl Health | Exit | 0 | $1.59 | $1.1M | −662,584 | −$1.1M | |
| ALEC, Alector | Exit | 0 | $2.96 | $521K | −175,866 | −$521K |
Filings history
4 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 28 | $99.1B | +2367.2% | 13F-HR | 8/7/2026 | 000165204426000073 |
| 2026 Q1 | 26 | $4B | +55.7% | 13F-HR | 5/8/2026 | 000165204426000051 |
| 2025 Q4 | 29 | $2.6B | +7.1% | 13F-HR | 2/13/2026 | 000165204426000023 |
| 2025 Q3 | 37 | $2.4B | — | 13F-HR | 11/7/2025 | 000165204425000096 |
About
Alphabet Inc.
4 processed 13Fs on this site, 2025 Q3 to 2026 Q2
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- The Essays of Warren Buffett, 8th Ed., Warren Buffett, Lawrence A. Cunningham View on Amazon
- One Up On Wall Street (Lynch), Peter Lynch View on Amazon